Axon Therapy
K-Number: K210021 · 2021-06-11
ApplicantNeuralace Medical, Inc.
Decision Date2021-06-11
Product CodeQPL
Advisory CommitteeNE
DecisionSubstantially Equivalent
Device Summary
Axon Therapy is a medical device manufactured by Neuralace Medical, Inc.. It received FDA 510(k) clearance on 2021-06-11 under approval number K210021. The device is classified under product code QPL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Axon Therapy?
Axon Therapy is a medical device that received FDA 510(k) clearance on 2021-06-11. It is manufactured by Neuralace Medical, Inc.. The 510(k) number is K210021.
When was Axon Therapy approved by the FDA?
Axon Therapy received FDA 510(k) clearance on 2021-06-11, under approval number K210021.
What company makes Axon Therapy?
Axon Therapy is manufactured by Neuralace Medical, Inc..
What is the FDA product code for Axon Therapy?
The FDA product code for Axon Therapy is QPL.
Other Devices by Neuralace Medical, Inc.
Related Devices (Code: QPL)
K230014MagVenture Pain Therapy: MagPro R30, MagPro R30 with MagOption, MagPro X100, MagPro X100 with MagOptionTonica Elektronik A/S
K233364Axon TherapyNeuralace Medical, Inc.
K250309BTL-199BTL Industries, Inc.
K250286Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1)The Magstim Company Limited
K241785StarFormer (M008-3T)Fotona D.O.O.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.